PODD · 10-Q · 2026Q2 · Full report

Research and Development Expense

INSULET CORP · 2026-08-05 · Importance 64 · Surprise 56 · In source text

Research and development expense increased 20.0% to $88.1 million in the second quarter of 2026 and 33.7% to $177.8 million for the first six months. Selling, general and administrative expense increased 33.8% to $344.8 million in the quarter and 27.7% to $662.1 million year to date. Total R&D and SG&A rose 30.4% year over year to $839.9 million for the first six months, exceeding half of revenue. Stock-based compensation contributed $40.9 million to operating expenses year to date, including $33.7 million in SG&A and $6.8 million in R&D.

Key facts

• Research and development expenses for the six months ended June 30, 2026 increased $44.8 million, or 33.7%, to $177.8 million, compared with $133.0 million for the six months ended June 30, 2025. source
• Research and development expenses for the three months ended June 30, 2026 increased $14.7 million, or 20.0%, to $88.1 million, compared with $73.4 million for the three months ended June 30, 2025. source
• Research and development expenses as a percent of revenue was 11.0% and 11.3% for the three months ended June 30, 2026 and 2025, respectively. source
• Research and development expenses as a percent of revenue was 11.4% and 10.9% for the six months ended June 30, 2026 and 2025, respectively. source
• Research and development expenses for the three months ended June 30, 2026: $88.1 million; for the six months ended June 30, 2026: $177.8 million. source
• The Company recorded stock-based compensation expense of $19.7 million and $40.9 million for the three and six months ended June 30, 2026, respectively (SG&A $16.0 and $33.7; R&D $3.5 and $6.8; Cost of revenue $0.2 and $0.5). source

Impact estimates